Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


29.06.2026

1 Am J Transl Res
1 Anal Methods
1 Appl Microbiol Biotechnol
1 Arch Gynecol Obstet
2 Asian Pac J Cancer Prev
1 Autism
1 Biol Direct
1 Biomed Phys Eng Express
2 Biomedicines
1 Biosens Bioelectron
1 BMC Biol
1 BMC Biotechnol
3 BMC Cancer
1 BMC Health Serv Res
3 BMC Infect Dis
1 BMC Med Imaging
1 BMC Prim Care
2 BMC Public Health
3 BMC Womens Health
1 BMJ
1 BMJ Public Health
2 Brachytherapy
1 Cancer Biol Med
1 Cancer Causes Control
1 Cancer Med
1 Cell Div
1 Cell Mol Biol (Noisy-le-grand)
1 Cell Rep
2 Clin Transl Radiat Oncol
1 Curr Oncol
1 Curr Opin Oncol
1 Dalton Trans
2 Diagnostics (Basel)
1 Eur J Obstet Gynecol Reprod Biol
1 Front Cell Dev Biol
1 Front Immunol
1 Front Netw Physiol
1 Front Oncol
1 Front Public Health
2 Genes (Basel)
1 Hereditas
1 Hum Cell
2 Hum Vaccin Immunother
1 IET Syst Biol
1 Infect Agent Cancer
1 Int J Cancer
1 Int J Equity Health
2 Int J Gynecol Cancer
4 Int J Mol Sci
2 Int J Womens Health
1 J Ethnopharmacol
1 J Extracell Vesicles
1 J Health Psychol
2 J Low Genit Tract Dis
1 J Mater Chem B
2 J Med Virol
1 J Prim Health Care
1 J Radiat Res
1 J Transl Med
2 JAMA Netw Open
1 JCO Glob Oncol
1 JMIR Res Protoc
1 Life (Basel)
1 Nat Med
1 NPJ Precis Oncol
1 Onco Targets Ther
1 Oncologist
3 Pathogens
2 PLoS One
1 Polymers (Basel)
1 Radiat Oncol
1 Radiol Imaging Cancer
1 Radiother Oncol
1 Reprod Health
1 Res Sq
1 Rev Assoc Med Bras (1992)
4 Sci Rep
1 Taiwan J Obstet Gynecol
1 Technol Cancer Res Treat
1 Transl Oncol
2 Virol J
1 Viruses
2 Womens Health Issues
1 World J Surg Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Transl Res

  1. BAI Y, Liang Y
    Comparison of ThinPrep cytology and high-risk human papillomavirus testing with different triage protocols for cervical cancer screening.
    Am J Transl Res. 2026;18:4314-4325.
    PubMed         Abstract available


    Anal Methods

  2. DONG X, Zhang J, Liu W
    A turn-on fluorescent biosensor based on CdTe quantum dots for sensitive and selective detection of APE1 activity in cervical cancer cell lysates.
    Anal Methods. 2026 Jun 24. doi: 10.1039/d6ay00808.
    PubMed         Abstract available


    Appl Microbiol Biotechnol

  3. DONG H, Zhang J, Wu L, Zhang X, et al
    Human papillomavirus 18 E6-specific Affibody inhibits cervical cancer cell proliferation and induces apoptosis.
    Appl Microbiol Biotechnol. 2026 Jun 26. doi: 10.1007/s00253-026-13903.
    PubMed         Abstract available


    Arch Gynecol Obstet

  4. HEMPEL S, Gross S, Steinkasserer L, Theis L, et al
    Comparison of three different hpv self-sampling tools - a subanalysis of the prospective, randomized hannover self-collection study.
    Arch Gynecol Obstet. 2026;313:210.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  5. ABRAHAM A, Mahajan S, Padda P, Kaur J, et al
    Assessment of Total Delays and Their Associated Factors among Breast, Cervical, and Head and Neck Cancers in Northwestern India: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2026;27:2097-2105.
    PubMed         Abstract available

  6. BODHARE T, Bele S, Rajh B, Karthikeyan V, et al
    Awareness of Cervical Cancer, Willingness, and Barriers to Cervical Cancer Screening among Women in Madurai: A Cross-Sectional Study in South India.
    Asian Pac J Cancer Prev. 2026;27:2053-2060.
    PubMed         Abstract available


    Autism

  7. MURDOCH S, Donaghy B, Grant A, Sheen K, et al
    Exploring Autistic People's Experiences of and Attitudes Towards Cervical Screening: A Mixed-Methods Study.
    Autism. 2026;30:1738-1748.
    PubMed         Abstract available


    Biol Direct

  8. ZHAO Y, Liu R, Li M, Feng M, et al
    Bovine lactoferrin induces apoptosis and modulates the transcriptomic landscape of HeLa cervical cancer cells.
    Biol Direct. 2026 Jun 26. doi: 10.1186/s13062-026-00859.
    PubMed         Abstract available


    Biomed Phys Eng Express

  9. JIAN J, Xu L, Gong C, Huang Y, et al
    Transformer-based magnetic resonance-to-computed tomography synthesis for radiotherapy for cervical cancer: model development and clinical evaluation.
    Biomed Phys Eng Express. 2026 Jun 24. doi: 10.1088/2057-1976.
    PubMed         Abstract available


    Biomedicines

  10. AYAG ME, Tuncer MC, Ozdemir I
    Gallic Acid Enhances Carboplatin-Induced Antitumoral Responses in Cervical Cancer Cells Through Oxidative Stress-Associated Mitochondrial and Apoptotic Mechanisms.
    Biomedicines. 2026;14:1399.
    PubMed         Abstract available

  11. JIAO B, Wang D, Wei J, Guan S, et al
    Sevoflurane-Associated Plasma Extracellular Vesicles Promote Aggressive Phenotypes in Cervical Cancer Cells with Concurrent DG Remodeling and EGFR/PKCalpha/NF-kappaB Activation.
    Biomedicines. 2026;14:1333.
    PubMed         Abstract available


    Biosens Bioelectron

  12. PENG L, Zhang Q, Zhang L, Dai Q, et al
    Intra-nanocomposite resonance energy transfer-based electrochemiluminescence biosensor for cervical cancer microRNA assay.
    Biosens Bioelectron. 2026;311:118937.
    PubMed         Abstract available


    BMC Biol

  13. ZHANG B, Lin Y, Xie S, Zhu X, et al
    Decoding the association between platinum resistance and HPV status in cervical cancer using organoid models.
    BMC Biol. 2026 Jun 26. doi: 10.1186/s12915-026-02665.
    PubMed         Abstract available


    BMC Biotechnol

  14. FENG M, Yu Y, Du J, Wang H, et al
    Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.
    BMC Biotechnol. 2026 Jun 23. doi: 10.1186/s12896-026-01193.
    PubMed         Abstract available


    BMC Cancer

  15. CHEN Y, Li S, Huang J, Huang X, et al
    Cervical pathology outcomes in the setting of completely normal colposcopic impressions.
    BMC Cancer. 2025;25:1691.
    PubMed         Abstract available

  16. FARZANEH F, Soltani A, Dastyar F, Mohammadi M, et al
    AI-Driven predictive modeling of cervical intraepithelial neoplasia severity: a comprehensive analysis with clinical adoption frameworks.
    BMC Cancer. 2025;25:1521.
    PubMed         Abstract available

  17. WANG XC, Xu XL, Wang SY, Cheng H, et al
    Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy.
    BMC Cancer. 2025;25:1043.
    PubMed         Abstract available


    BMC Health Serv Res

  18. NANYONJO G, De Paepe E, Wambuzi M, Kasule S, et al
    Perceived barriers and facilitators to conventional cervical screening: a qualitative study among women, primary health workers and community representatives in Uganda.
    BMC Health Serv Res. 2026;26:867.
    PubMed         Abstract available


    BMC Infect Dis

  19. OLTIEVA MP, Alieva DA, Kizi Abdusattorova SB, Sharipova IP, et al
    Epidemiology of high-risk HPV in Uzbekistan among 44,000 women - genotypes, risk profiles and screening needs in Uzbekistan.
    BMC Infect Dis. 2025;25:1721.
    PubMed         Abstract available

  20. ADDIS NA, Yigzaw KT, Ahmed OA, Yemru GM, et al
    Cervical schistosomiasis masquerading as invasive carcinoma: a case report.
    BMC Infect Dis. 2025;25:1654.
    PubMed         Abstract available

  21. CHEN M, Wang Y, Dong B, Zhang Y, et al
    Epidemiological analysis of human papillomavirus infection in senior women: a hospital-based retrospective study.
    BMC Infect Dis. 2025;25:1378.
    PubMed         Abstract available


    BMC Med Imaging

  22. XIE K, Hua Q, Gao L, Sun J, et al
    SegMambaDP: a long-range sequential modeling mamba network for 3D dose prediction in radiotherapy.
    BMC Med Imaging. 2025;25:527.
    PubMed         Abstract available


    BMC Prim Care

  23. SIGVARDSSON D, MacLean A, Hoonk A, Ali T, et al
    Barriers and implementation strategies for physical activity on prescription (PAP): healthcare personnel and management perspectives in Sweden-An explanatory sequential study design.
    BMC Prim Care. 2025;26:302.
    PubMed         Abstract available


    BMC Public Health

  24. LEMOUPA MAKAJIO SH, Murtas M, Kenfack B, Vassilakos P, et al
    Interventions involving community health workers and their effect on cervical cancer screening uptake in sub-Saharan Africa: a systematic review.
    BMC Public Health. 2026 Jun 19. doi: 10.1186/s12889-026-28109.
    PubMed         Abstract available

  25. JUAREZ-LEON V, Calderon-Solano D, Poterico JA, Ybaseta-Medina J, et al
    Factors associated with parental acceptance of the HPV vaccine in girls from metropolitan Lima, Peru.
    BMC Public Health. 2025;25:2334.
    PubMed         Abstract available


    BMC Womens Health

  26. DE SEIXAS CARVALHO B, Jordao PM, de Andrade CV, da Costa ACC, et al
    Swede Score can predict high-grade cervical intraepithelial neoplasia without previous cytology in colposcopies with transformation zone types 1 or 2.
    BMC Womens Health. 2026;26:158.
    PubMed         Abstract available

  27. LI X, Sun B, Huang X
    Trends and projections of global gynaecological cancer burden: age-period-cohort insights from Global Burden of Disease 2021.
    BMC Womens Health. 2025;25:502.
    PubMed         Abstract available

  28. XIAONAN L, MeiHan C, Dan H
    Vaginal Microenvironment-Driven neural network model for predicting multiple HPV co-infections: a machine learning clinical decision framework.
    BMC Womens Health. 2025;25:489.
    PubMed         Abstract available


    BMJ

  29. MAHASE E
    HPV jab: cervical cancer deaths fall to zero in vaccinated young women, research shows.
    BMJ. 2026;393:e100047.
    PubMed        


    BMJ Public Health

  30. TESHA NA, Jaiswal N, Ruhago G, Geue C, et al
    Cost and cost-effectiveness of cervical cancer HPV DNA self-sampling: a systematic review.
    BMJ Public Health. 2026;4:e004405.
    PubMed         Abstract available


    Brachytherapy

  31. ONG P, Jainar CJ, Chua VH, Cabrera SM, et al
    Integrating ultrasound into cervical brachytherapy planning: A technical note with an illustrative case.
    Brachytherapy. 2026;25:640-647.
    PubMed         Abstract available

  32. TYAGI P, Rivera A, Chakraborty S, Bhattacharyya T, et al
    Patterns of anesthesia(AS) and analgesia(AG) practice in gynecological brachytherapy in India.
    Brachytherapy. 2026;25:632-639.
    PubMed         Abstract available


    Cancer Biol Med

  33. ZHENG B, Fan D, Zhou S
    Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies.
    Cancer Biol Med. 2026 Jun 22:j.issn.2095-3941.2026.0139.
    PubMed        


    Cancer Causes Control

  34. THOMAS V, Devadasan JDC, John NO, Reddy JK, et al
    Serum human papilloma virus detection following treatment of cervical cancer: prevalence and its correlation with recurrence.
    Cancer Causes Control. 2026;37:111.
    PubMed         Abstract available


    Cancer Med

  35. KULKARNI A, Wiener HW, Boitano TKL, Szychowski JM, et al
    Charleson and Elixhauser Comorbidity Indices in Predicting Mortality Among Young and Old Cervical Cancer Patients.
    Cancer Med. 2026;15:e71973.
    PubMed         Abstract available


    Cell Div

  36. GAO F, Zeng Y, Jia L, He J, et al
    Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression.
    Cell Div. 2026 Jun 25. doi: 10.1186/s13008-026-00182.
    PubMed         Abstract available


    Cell Mol Biol (Noisy-le-grand)

  37. OUEDRAOGO TC, Bazie BVEJT, Simpore A, Ouattara AK, et al
    Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.
    Cell Mol Biol (Noisy-le-grand). 2026;72:30-43.
    PubMed         Abstract available


    Cell Rep

  38. POULAIN F, Malassigne V, Roncarati P, Puech J, et al
    Clonal origin and early lineage divergence in adenosquamous carcinoma.
    Cell Rep. 2026;45:117470.
    PubMed         Abstract available


    Clin Transl Radiat Oncol

  39. LAMBA P
    Comment on: "Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.".
    Clin Transl Radiat Oncol. 2026;59:101166.
    PubMed        

  40. SITTIWONG W, Dankulchai P, Wongsuwan P, Prasartseree T, et al
    Corrigendum to "Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features by a Commercial Software as Survival Predictors in Radiotherapy for Cervical Cancer" [Clin. Transl. Radiat. Oncol. 53 (2025) 100965].
    Clin Transl Radiat Oncol. 2026;59:101128.
    PubMed         Abstract available


    Curr Oncol

  41. LEE TS, Wang YC
    Stage-Specific Healthcare Costs in Cervical Cancer and Cervical Intraepithelial Neoplasia: A Population-Based Analysis Informing Value-Based Oncology and Equitable Prevention.
    Curr Oncol. 2026;33:329.
    PubMed         Abstract available


    Curr Opin Oncol

  42. CENGIZ M, Zaim OC, Temiz BE, Grigore M, et al
    Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.
    Curr Opin Oncol. 2026 Jun 23. doi: 10.1097/CCO.0000000000001255.
    PubMed         Abstract available


    Dalton Trans

  43. ZHANG Y, Ye Y, Zhong Q, Yan Z, et al
    Advances and prospects of MIL-based drug delivery systems in the diagnosis and treatment of cervical cancer.
    Dalton Trans. 2026 Jun 22. doi: 10.1039/d6dt00965.
    PubMed         Abstract available


    Diagnostics (Basel)

  44. LUCA DC, Cirimbei C, Ionescu SO, Rotaru V, et al
    Correction: Luca et al. Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative Synthesis. Diagnostics 2026, 16, 1224.
    Diagnostics (Basel). 2026;16:1764.
    PubMed         Abstract available

  45. ALYAMI AS
    Advanced Diffusion MRI in Cervical Cancer: A Comprehensive Review.
    Diagnostics (Basel). 2026;16:1870.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  46. LIU F, Wang L, Sun Q, Jing S, et al
    Adverse events associated with immune checkpoint inhibitors in cervical cancer: A systematic review and meta-analysis of randomized controlled trials.
    Eur J Obstet Gynecol Reprod Biol. 2026;324:115263.
    PubMed         Abstract available


    Front Cell Dev Biol

  47. BOU ANTOUN N, Grose RP, Walker AJ, Modjtahedi H, et al
    FGFR inhibitor resistance in cervical cancer: a role for integrin alpha2 and mTOR signalling.
    Front Cell Dev Biol. 2026;14:1863679.
    PubMed         Abstract available


    Front Immunol

  48. SUI L, Yin R
    Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990-2025): a multi-database bibliometric analysis.
    Front Immunol. 2026;17:1835957.
    PubMed         Abstract available


    Front Netw Physiol

  49. GOMES M, Li Z, Olaitan A, Gentry-Maharaj A, et al
    Predictive modeling for cervical cancer: existing AI approaches and the emerging role of vaginal microbiome.
    Front Netw Physiol. 2026;6:1799486.
    PubMed         Abstract available


    Front Oncol

  50. RAKHMANKULOVA A, Sakko Y, Gaipov A, Atageldiyeva K, et al
    Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study.
    Front Oncol. 2026;16:1820759.
    PubMed         Abstract available


    Front Public Health

  51. WANG J, Wang X, Xu J, Xu Q, et al
    Cost-effectiveness of single-dose versus two-dose HPV vaccination: a Markov cohort modelling analysis of a Kenya-India LMIC composite.
    Front Public Health. 2026;14:1833764.
    PubMed         Abstract available


    Genes (Basel)

  52. TERRINONI M, Caputo V, Palisciano M, Mascellino G, et al
    Non-Coding RNAs as Emerging Biomarkers in HPV-Associated Cervical Precancer and Cancer: Molecular Mechanisms and Clinical Perspectives.
    Genes (Basel). 2026;17:714.
    PubMed         Abstract available

  53. MOUSTAKLI E, Makrydimas S, Oikonomou ED, Nakou A, et al
    The Microbiome-Mitochondria-Extracellular Vesicle Axis in HPV Persistence and Cervical Carcinogenesis.
    Genes (Basel). 2026;17:655.
    PubMed         Abstract available


    Hereditas

  54. SUN L, Tunishahan A, Li X
    M2 macrophage-derived exosomes promote the malignant progression and glycolysis of cervical cancer via Msi1.
    Hereditas. 2026 Jun 25. doi: 10.1186/s41065-026-00703.
    PubMed         Abstract available


    Hum Cell

  55. ZHANG T, Yan Y, Yuan S, Yang T, et al
    A novel HPV E6/E7-regulated long noncoding RNA CRL suppresses cervical intraepithelial neoplasia progression by attenuating ferroptosis.
    Hum Cell. 2026;39:90.
    PubMed         Abstract available


    Hum Vaccin Immunother

  56. COOPER S, Wiysonge CS, Jama NA, Leon N, et al
    Understanding the roots of hesitancy to unlock the game-changing impact of HPV vaccination: Insights from a global qualitative evidence synthesis.
    Hum Vaccin Immunother. 2026;22:2681769.
    PubMed         Abstract available

  57. BAI J, Cui XL, Bo SJ, Sun L, et al
    Using peripheral blood indicators and T cells subsets to evaluate the efficacy of immunotherapy for advanced and recurrent cervical cancer.
    Hum Vaccin Immunother. 2026;22:2664301.
    PubMed         Abstract available


    IET Syst Biol

  58. CHEN L, Li C, Xu C, Cai R, et al
    Unravelling the Mechanism of Compound Kushen Injection in Treating Cervical Cancer Through Ferroptosis Regulation: An Integrated Network Pharmacology and Molecular Docking Study.
    IET Syst Biol. 2026;20:e70075.
    PubMed         Abstract available


    Infect Agent Cancer

  59. MANYANGA P, Vasavada A, Murwira S, Gondongwe L, et al
    Motivations and hesitations for cervical cancer screening: considerations for scale-up of human papilloma virus (HPV) testing within HIV care in Zimbabwe.
    Infect Agent Cancer. 2026 Jun 19. doi: 10.1186/s13027-026-00773.
    PubMed         Abstract available


    Int J Cancer

  60. CHOKUNONGA E, Chirenje ZM, Borok M, Makunike-Mutasa R, et al
    Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990-2019.
    Int J Cancer. 2026;159:844-852.
    PubMed         Abstract available


    Int J Equity Health

  61. SAD SA, Iftikhar L, Chamout M
    Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health.
    Int J Equity Health. 2025;24:308.
    PubMed         Abstract available


    Int J Gynecol Cancer

  62. JOURA E, Chatzistamatiou K, Gultekin M, Sehouli J, et al
    European Society of Gynaecological Oncology/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screening.
    Int J Gynecol Cancer. 2026;36:104794.
    PubMed         Abstract available

  63. CARUSO G, Colombo N
    ADC-opoly in endometrial and cervical cancer: expanding the board.
    Int J Gynecol Cancer. 2026;36:104786.
    PubMed        


    Int J Mol Sci

  64. SUAREZ-RICO DO, Rizo de la Torre LDC, Zermeno-Ruiz M, Balleza-Alejandri LR, et al
    Bidirectional Interactions Between Cervicovaginal Microbiota and Human Papillomavirus Drive Persistence and Disease Progression.
    Int J Mol Sci. 2026;27:5616.
    PubMed         Abstract available

  65. GACUTA E, Zajkowska M, Lawicki M, Urban J, et al
    Diagnostic Potential of Selected Matrilysins and Stromelysins in the Diagnosis of Gynecological Malignancies Based on ROC Curve Analysis.
    Int J Mol Sci. 2026;27:5592.
    PubMed         Abstract available

  66. ZHANG L, Ouyang Z, Tan J, Li W, et al
    Mechanistic Study of Matrix Stiffness Promoting Lymph Node Metastasis in Cervical Cancer by Regulating NETs Formation via Piezo1.
    Int J Mol Sci. 2026;27:5431.
    PubMed         Abstract available

  67. JELSKI W, Okrasinska S, Mroczko J, Rutkowska W, et al
    MicroRNAs as Biomarkers of Cervical Cancers.
    Int J Mol Sci. 2026;27:5330.
    PubMed         Abstract available


    Int J Womens Health

  68. ZHANG Y, Wu Y, Wang Y, Yang J, et al
    Perioperative Symptom Trajectories and a Risk Prediction Model for Cervical Cancer: A Prospective Longitudinal Study.
    Int J Womens Health. 2026;18:613006.
    PubMed         Abstract available

  69. CHEN Y, Wen T, Wen X, Lai Z, et al
    Treatment of HER2-Positive Brain Metastasis from Cervical Cancer Using Multimodal Therapy Including Pyrotinib: A Case Report.
    Int J Womens Health. 2026;18:607409.
    PubMed         Abstract available


    J Ethnopharmacol

  70. DANG S, Tang X, Li Q, Wu J, et al
    Corrigendum to "Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration" [J Ethnopharmacol. (2026) 358 120966].
    J Ethnopharmacol. 2026 Jun 24:122028. doi: 10.1016/j.jep.2026.122028.
    PubMed        


    J Extracell Vesicles

  71. LI J, Huang X, Abulizi G, Hasim A, et al
    Exosomal Oleic Acid Promotes Lymphangiogenesis and Nodal Metastasis in Cervical Cancer via the AKT/mTOR Pathway.
    J Extracell Vesicles. 2026;15:e70328.
    PubMed         Abstract available


    J Health Psychol

  72. RICKFORD R, Rogers M, Gunn R, Wearmouth L, et al
    Facilitating engagement: Individual meaning-making and relationship-based trust in women's experiences of cervical screening.
    J Health Psychol. 2026;31:3196-3209.
    PubMed         Abstract available


    J Low Genit Tract Dis

  73. CYRIAC J, Theel ES, Long ME, Maxson JA, et al
    Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
    J Low Genit Tract Dis. 2026;30:161-168.
    PubMed         Abstract available

  74. OZDEMIR BG, Agakishiyeva L, Bilgi A, Celik C, et al
    Evaluation of Clitoral Artery Doppler Parameters After Brachytherapy and Its Effects On Sexual Functions.
    J Low Genit Tract Dis. 2026;30:280-284.
    PubMed         Abstract available


    J Mater Chem B

  75. GOSECKA M, Gosecki M, Urbaniak M, Wielgus E, et al
    Unimolecular micelles as an effective carrier of poorly water-soluble nifuratel for selective in vivo anticervical cancer therapy via mucoadhesive dynamic hydrogels.
    J Mater Chem B. 2026;14:7543-7557.
    PubMed         Abstract available


    J Med Virol

  76. TALPE-NUNES V, Ribeiro AL, Nunes RA, Sobrinho JS, et al
    GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis.
    J Med Virol. 2026;98:e71034.
    PubMed         Abstract available

  77. JERIP AR, Noni V, Senian AA, Bong ACS, et al
    Mismatch Between Vaccine Targets and Endemic HPV Genotypes in Sarawak, East Malaysia: Implications for Cervical Cancer Prevention.
    J Med Virol. 2026;98:e71010.
    PubMed         Abstract available


    J Prim Health Care

  78. SLATER T, Stevenson K, Adcock A, Clueard MA, et al
    Opportunities to flip the narrative from burden to action for young women joining the National Cervical Screening Programme in Aotearoa New Zealand: a Kaupapa Maori qualitative exploration of experiences and knowledge of cervical screening for 18-30 y
    J Prim Health Care. 2026;18:141-148.
    PubMed         Abstract available


    J Radiat Res

  79. SAITO T, Sho K, Saida T, Sumiya T, et al
    Mid-treatment MRI-based tumor volume reduction rate as a continuous prognostic factor after chemoradiation for cervical cancer: development and two-center internal-external validation.
    J Radiat Res. 2026 Jun 25:rrag043. doi: 10.1093.
    PubMed         Abstract available


    J Transl Med

  80. CHEN M, Zhang W, Wu X, Wang H, et al
    Design, synthesis and verification of HPV16 and HPV18 multiple antigens peptides.
    J Transl Med. 2025;24:38.
    PubMed         Abstract available


    JAMA Netw Open

  81. SUH-BURGMANN EJ, Hung YY, Seo T, Carlson K, et al
    Home Cervical Cancer Screening Uptake in a Large Community-Based General Screening Population.
    JAMA Netw Open. 2026;9:e2620343.
    PubMed        

  82. OLADOYIN OO, Cuccaro P, Savas LS, Yu R, et al
    Trust in Cancer Information Sources and Awareness of Human Papillomavirus as a Cause of Cervical Cancer Among US Adults.
    JAMA Netw Open. 2026;9:e2620133.
    PubMed         Abstract available


    JCO Glob Oncol

  83. KATARIA I, Jose S, Jebaraj P, Kumar R, et al
    Living With Loss: The Caregiver Journey and Unmet Needs Across the Cervical Cancer Care Continuum in India.
    JCO Glob Oncol. 2026;12:e2600031.
    PubMed         Abstract available


    JMIR Res Protoc

  84. MATSUNAGA R, Tamura J, Yamamoto K, Senuki K, et al
    Evaluation of the Efficacy of Human Papillomavirus Screening Compared With Cytology Screening in Pregnant Women: Protocol for a Prospective Multicenter Trial.
    JMIR Res Protoc. 2026;15:e86397.
    PubMed         Abstract available


    Life (Basel)

  85. RADU EA, Anton CI, Sima CS, Streinu-Cercel A, et al
    Beyond HPV in Eastern Europe: Genotype Distribution, Molecular Biomarkers, Vaginal Microbiome, and Implications for Cervical Cancer Prevention.
    Life (Basel). 2026;16:1039.
    PubMed         Abstract available


    Nat Med

  86. O'LEARY K
    HPV vaccination linked to dramatic reduction in cervical cancer deaths.
    Nat Med. 2026 Jun 25. doi: 10.1038/d41591-026-00033.
    PubMed        


    NPJ Precis Oncol

  87. YANG G, Wang W, Zhang C, Liu Y, et al
    Dynamic multimodal radiomic model for survival prediction in cervical cancer: a multi-cohort study.
    NPJ Precis Oncol. 2026 Jun 25. doi: 10.1038/s41698-026-01545.
    PubMed         Abstract available


    Onco Targets Ther

  88. YANG H, Zheng Q, Li X, Wang J, et al
    Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells.
    Onco Targets Ther. 2026;19:613657.
    PubMed         Abstract available


    Oncologist

  89. GU L, Zhu B, Liu C, Wu X, et al
    Genomic Determinants and an Exploratory Prognostic Model for Immunotherapy Outcomes in Recurrent or Metastatic Cervical Cancer.
    Oncologist. 2026 Jun 22:oyag236. doi: 10.1093.
    PubMed         Abstract available


    Pathogens

  90. SORBYE SW, Antonsen M, Richardsen E
    Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.
    Pathogens. 2026;15:657.
    PubMed         Abstract available

  91. VILLAZANA-CALDERON B, Jimenez-Wences H, Garcia-Chavez JN, Martinez-Ramirez I, et al
    HPV-16 E6 and E7 Oncoproteins Promote Cell Proliferation and Migration Through the miR-218-5p/PIK3C2A Axis.
    Pathogens. 2026;15:648.
    PubMed         Abstract available

  92. SORBYE SW, Falang BM, Antonsen M, Richardsen E, et al
    Genotype-Specific HPV mRNA Triage Improves Colposcopy Efficiency Compared with Cytology and ATHENA-Derived Triage: A Population-Based Study of HPV DNA-Positive Women.
    Pathogens. 2026;15:584.
    PubMed         Abstract available


    PLoS One

  93. EFFAH K, Ametefe DL, Amuah JE, Essel NOM, et al
    A collaborative cervical precancer screening strategy with concurrent HPV genotyping and visual inspection using alumni of a training centre across Ghana: The Rotary 'Protect Your Pearl' initiative.
    PLoS One. 2026;21:e0350573.
    PubMed         Abstract available

  94. SEDAGHAT SHAYEGAN G, Salehipour P, Najafi A, Modarressi MH, et al
    Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach.
    PLoS One. 2026;21:e0349088.
    PubMed         Abstract available


    Polymers (Basel)

  95. QIAO M, Wang X, Ren C, Li Q, et al
    Polymer-Based Biomaterials for Local Therapy in Cervical Cancer: A Mini-Review.
    Polymers (Basel). 2026;18:1460.
    PubMed         Abstract available


    Radiat Oncol

  96. SHEN J, Sun S, Xu Z, Wang X, et al
    A rapid semi-automated trajectory planning method for non-coplanar interstitial brachytherapy in cervical cancer using a greedy algorithm.
    Radiat Oncol. 2026 Jun 23. doi: 10.1186/s13014-026-02881.
    PubMed         Abstract available


    Radiol Imaging Cancer

  97. CHEN S, Zhang Y, Chen D, Dang J, et al
    AI-assisted Radiomic Model for Cervical Cancer Recurrence Prediction: A Multicenter Retrospective Study with Experimental Validation.
    Radiol Imaging Cancer. 2026;8:e250618.
    PubMed         Abstract available


    Radiother Oncol

  98. YANG XL, Li XM, Shi YG, Wei LC, et al
    Induction chemotherapy prior to definitive chemoradiotherapy in locally advanced cervical cancer patients: A multi-center cohort study.
    Radiother Oncol. 2026 Jun 26:111675. doi: 10.1016/j.radonc.2026.111675.
    PubMed         Abstract available


    Reprod Health

  99. BELAYNEH Y, Abneh AA, Mengist A, Kassie TD, et al
    Determinants of precancerous cervical lesions among women screened for cervical cancer at Debre Markos town public health facilities, Ethiopia.
    Reprod Health. 2026 Jun 24. doi: 10.1186/s12978-026-02399.
    PubMed         Abstract available


    Res Sq

  100. ENEH SC, Idemili-Aronu N, Jemisenia JO, Olakunde BO, et al
    Participation and Refusal in an Implementation Trial: Insights from the Accelerating Cervical Cancer Elimination through the Integration of Screen-and-Treat Services (ACCESS) Study.
    Res Sq [Preprint]. 2026 Jun 11:rs.3.rs-9798338. doi: 10.21203/rs.3.rs-9798338.
    PubMed         Abstract available


    Rev Assoc Med Bras (1992)

  101. BADEMCI EG, Soysal D, Gunes M, Zengin A, et al
    Early colposcopy in non-16/18 high-risk human papillomavirus positivity with normal cytology.
    Rev Assoc Med Bras (1992). 2026;72:e20252178.
    PubMed         Abstract available


    Sci Rep

  102. ZHANG H, Xie L, Liu Y, Yang H, et al
    Integrated bioinformatics, machine learning, and experimental validation identify a four-gene diagnostic signature for cervical cancer associated with PI3K/AKT signaling.
    Sci Rep. 2026;16:19576.
    PubMed         Abstract available

  103. SAKRAN W, Abdel-Hakim M, Abdel-Rashid RS
    Formulation, characterization and evaluation of cytotoxic potential for febuxostat loaded chitosomes against cervical cancer cells (Hela cells).
    Sci Rep. 2026;16:19198.
    PubMed         Abstract available

  104. V P, K H, Karthikeyan S, Murugadoss H, et al
    Health-related quality of life in patients with cervical cancer: a systematic review and meta-analysis of EQ?5D utility scores.
    Sci Rep. 2026 Jun 20. doi: 10.1038/s41598-026-58466.
    PubMed         Abstract available

  105. REGO RM, Vale DB, Campos CS, Vasconcelos L, et al
    Age distribution of high-risk HPV infection and cervical lesions in an unvaccinated adult Brazilian population within an organized screening program.
    Sci Rep. 2026;16:4453.
    PubMed         Abstract available


    Taiwan J Obstet Gynecol

  106. SOMPONGNAWAKIT K, Boonyapipat S, Saeaib N
    Pretreatment systemic immune-inflammatory index (SII) for a prognostic impact in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Taiwan J Obstet Gynecol. 2026;65:774-781.
    PubMed         Abstract available


    Technol Cancer Res Treat

  107. BUZUROVIC IM, Cormack RA
    A Novel Adjustable Tandem and Ring Applicator for Improved Dosimetry in Cervical Cancer HDR Brachytherapy.
    Technol Cancer Res Treat. 2026;25:15330338261463597.
    PubMed         Abstract available


    Transl Oncol

  108. YI H, Li S, Han Y, Li Q, et al
    The ESR1-MYH14 axis functions as a critical driver of cervical cancer progression and metastasis.
    Transl Oncol. 2026;71:102884.
    PubMed         Abstract available


    Virol J

  109. CORDOVIL DC, da Silva Reis LD, Ferreira LSS, Sequeira CG, et al
    High-risk oncogenic HPV genotypes in vulnerable women from the Amazon: a cross-sectional retrospective study.
    Virol J. 2026;23:164.
    PubMed         Abstract available

  110. MIYAMURA T, Mori S, Onuki M, Sekizawa A, et al
    Nuclear keratin 6A upregulates human papillomavirus oncogene expression through TEAD1 interaction.
    Virol J. 2025;22:202.
    PubMed         Abstract available


    Viruses

  111. RAKHAT A, Aimagambetova G
    Diagnostic Accuracy of Urine and Vaginal Self-Sampling for Detection of High-Risk Human Papillomavirus: A Systematic Review and Meta-Analysis.
    Viruses. 2026;18:681.
    PubMed         Abstract available


    Womens Health Issues

  112. PERKINS RB, Fontenot HB, Manassaram-Baptiste D, Scott AM, et al
    The Prevention Gap: Cervical Cancer in Older Women.
    Womens Health Issues. 2026 Jun 20:S1049-3867(26)00074.
    PubMed        

  113. OWENS H, Griner SB, Beckstead J, Kim E, et al
    Predictors of Intention to Use At-Home HPV Testing: Health Belief Factors and Potential Moderation by Decision-Making Style.
    Womens Health Issues. 2026;36:286-293.
    PubMed         Abstract available


    World J Surg Oncol

  114. XIE Y, Yu C, Wang M, Lin Y, et al
    HMGB1 promotes radiotherapy resistance in human cervical cancer HeLa cells through regulating the AMPK/mTOR signaling.
    World J Surg Oncol. 2026 Jun 23. doi: 10.1186/s12957-026-04461.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum